Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

59
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
59
The Thyroid Gland01:23

The Thyroid Gland

7.0K
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
7.0K
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

36
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
36
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

7.2K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
7.2K
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

33
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
33
Goiter01:27

Goiter

40
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
40

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Using digital tools to improve diabetes care in India with continuous glucose monitoring.

Therapeutic advances in endocrinology and metabolism·2025
Same author

Impact of My Dose Coach App Frequency of Use on Clinical Outcomes in Type 2 Diabetes.

Diabetes therapy : research, treatment and education of diabetes and related disorders·2022
Same author

Diabetes in India: A Dualistic Approach Beckons.

Indian journal of endocrinology and metabolism·2022
Same author

Barophenotypic Characterization - The key to Person Centric Management of Obesity.

Indian journal of endocrinology and metabolism·2022
Same author

Postprandial Glucose Excursions in Asian Versus Non-Asian Patients with Type 2 Diabetes: A Post Hoc Analysis of Baseline Data from Phase 3 Randomised Controlled Trials of IDegAsp.

Diabetes therapy : research, treatment and education of diabetes and related disorders·2022
Same author

Management of diabetes mellitus through teleconsultation during COVID-19 and similar scenarios - Guidelines from Indian Council of Medical Research (ICMR) expert group.

Diabetes & metabolic syndrome·2021

Related Experiment Video

Updated: May 5, 2026

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy
05:12

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy

Published on: May 12, 2023

5.8K

Obstetric controversies in thyroidology.

Ambika Gopalakrishnan Unnikrishnan1, Shilpa Bhosale, Sanjay Kalra

  • 1Department of Endocrinology and Diabetes, Chellaram Diabetes Institute, Pune, India.

Indian Journal of Endocrinology and Metabolism
|November 20, 2013
PubMed
Summary

Thyroid disease in pregnancy presents challenges, particularly hypothyroidism linked to adverse outcomes. This review examines thyroid hormone deficiency

Area of Science:

  • Endocrinology
  • Obstetrics
  • Maternal-Fetal Medicine

Background:

  • Thyroid disorders are prevalent in women and pose significant challenges during pregnancy.
  • Maternal hypothyroidism and hypothyroxinemia are associated with adverse feto-maternal outcomes.
  • Managing thyroid dysfunction in pregnant individuals requires careful consideration by endocrinologists.

Purpose of the Study:

  • To discuss the controversy surrounding first-trimester thyroid hormone deficiency and its impact on fetal brain development.
  • To review obstetric controversies in managing hyperthyroidism during pregnancy.
  • To explore indications for TSH receptor antibody measurements and fetal thyroid monitoring.

Main Methods:

  • Literature review of current research on thyroid disorders in pregnancy.
Keywords:
Hypothyroidismhyperthyroidismpregnancy

More Related Videos

Substernal Thyroid Biopsy Using Endobronchial Ultrasound-guided Transbronchial Needle Aspiration
10:19

Substernal Thyroid Biopsy Using Endobronchial Ultrasound-guided Transbronchial Needle Aspiration

Published on: November 10, 2014

24.6K
Mixed Reality Assisted Radical Endoscopic Thyroidectomy
08:06

Mixed Reality Assisted Radical Endoscopic Thyroidectomy

Published on: January 31, 2025

832

Related Experiment Videos

Last Updated: May 5, 2026

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy
05:12

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy

Published on: May 12, 2023

5.8K
Substernal Thyroid Biopsy Using Endobronchial Ultrasound-guided Transbronchial Needle Aspiration
10:19

Substernal Thyroid Biopsy Using Endobronchial Ultrasound-guided Transbronchial Needle Aspiration

Published on: November 10, 2014

24.6K
Mixed Reality Assisted Radical Endoscopic Thyroidectomy
08:06

Mixed Reality Assisted Radical Endoscopic Thyroidectomy

Published on: January 31, 2025

832
  • Discussion of clinical controversies and management strategies.
  • Analysis of feto-maternal outcomes related to maternal thyroid status.
  • Main Results:

    • Maternal thyroid hormone deficiency in early pregnancy is a concern for fetal neurodevelopment.
    • Management of hyperthyroidism in pregnancy involves specific considerations regarding antibody measurements and fetal monitoring.
    • Evidence synthesis on the link between maternal thyroid status and pregnancy outcomes.

    Conclusions:

    • Addressing thyroid dysfunction in pregnancy is crucial for optimizing maternal and fetal health.
    • Further research is needed to clarify the precise impact of thyroid hormone levels on fetal development.
    • Standardized guidelines for managing thyroid disease in pregnant women are essential.